JEFFREY F EISENBERG Insider Trading Transactions
Get free email notifications about insider trading for JEFFREY F EISENBERG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JEFFREY F EISENBERG. JEFFREY F EISENBERG is Executive Vice President in NOVEN PHARMACEUTICALS INC ($NOVN) and Executive VP and Interim CEO in NOVEN PHARMACEUTICALS INC ($NOVN) and Sr. VP - Strategic Alliances in NOVEN PHARMACEUTICALS INC ($NOVN) and VP & General Counsel in NOVEN PHARMACEUTICALS INC ($NOVN) and in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and CEO in Xenetic Biosciences, Inc. ($XBIO) and Chief Executive Officer in Xenetic Biosciences, Inc. ($XBIO) and COO in Xenetic Biosciences, Inc. ($XBIO).
Latest Insider Trading Transactions of JEFFREY F EISENBERG
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, MBVX, NOVN, XBIO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 22 2021 | XBIO | Xenetic Bioscience ... | EISENBERG JEFFREY F | Chief Executive Off ... | Option Exercise | A | 2.60 | 100,000 | 260,000 | 100,000 | |
Dec 06 2019 | XBIO | Xenetic Bioscience ... | EISENBERG JEFFREY F | Chief Executive Off ... | Option Exercise | A | 1.31 | 230,000 | 301,300 | 230,000 | |
Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | EISENBERG JEFFREY F | Option Exercise | A | 2.04 | 35,000 | 71,400 | 35,000 | ||
Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | EISENBERG JEFFREY F | Option Exercise | A | 2.04 | 35,000 | 71,400 | 35,000 | ||
Jan 24 2018 | MBVX | MABVAX THERAPEUTIC ... | EISENBERG JEFFREY F | Sell | S | 0.84 | 17,998 | 15,118 | 64,558 | 82.6 K to 64.6 K (-21.80 %) | |
Jan 24 2018 | MBVX | MABVAX THERAPEUTIC ... | EISENBERG JEFFREY F | Sell | S | 0.87 | 17,444 | 15,176 | 82,556 | 100 K to 82.6 K (-17.44 %) | |
Jan 12 2018 | MBVX | MABVAX THERAPEUTIC ... | EISENBERG JEFFREY F | Option Exercise | M | 0.00 | 100,000 | 0 | 1,543 | ||
Jan 12 2018 | MBVX | MABVAX THERAPEUTIC ... | EISENBERG JEFFREY F | Buy | M | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K | |
Oct 30 2017 | XBIO | Xenetic Bioscience ... | EISENBERG JEFFREY F | CEO | Option Exercise | A | 2.11 | 250,000 | 527,500 | 250,000 | |
Oct 30 2017 | XBIO | Xenetic Bioscience ... | EISENBERG JEFFREY F | CEO | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Oct 04 2017 | MBVX | MABVAX THERAPEUTIC ... | EISENBERG JEFFREY F | Option Exercise | A | 0.00 | 75,790 | 0 | 75,790 | ||
Sep 18 2017 | MBVX | MABVAX THERAPEUTIC ... | EISENBERG JEFFREY F | Option Exercise | A | 0.00 | 24,210 | 0 | 24,210 | ||
Jun 14 2017 | MBVX | MABVAX THERAPEUTIC ... | EISENBERG JEFFREY F | Option Exercise | A | 1.57 | 20,000 | 31,400 | 20,000 | ||
May 23 2017 | MBVX | MABVAX THERAPEUTIC ... | EISENBERG JEFFREY F | Option Exercise | A | 1.80 | 50,000 | 90,000 | 50,000 | ||
Jan 03 2017 | MBVX | MABVAX THERAPEUTIC ... | EISENBERG JEFFREY F | Option Exercise | A | 3.38 | 2,300 | 7,774 | 2,300 | ||
Dec 06 2016 | XBIO | Xenetic Bioscience ... | EISENBERG JEFFREY F | COO | Option Exercise | A | 3.40 | 75,100 | 255,340 | 230,000 | |
Dec 06 2016 | XBIO | Xenetic Bioscience ... | EISENBERG JEFFREY F | COO | Option Exercise | A | 3.40 | 75,100 | 255,340 | 154,900 | |
Dec 06 2016 | XBIO | Xenetic Bioscience ... | EISENBERG JEFFREY F | COO | Option Exercise | A | 3.40 | 75,100 | 255,340 | 79,800 | |
Dec 06 2016 | XBIO | Xenetic Bioscience ... | EISENBERG JEFFREY F | COO | Option Exercise | A | 3.40 | 4,700 | 15,980 | 4,700 | |
Aug 30 2016 | MBVX | MABVAX THERAPEUTIC ... | EISENBERG JEFFREY F | Option Exercise | A | 5.00 | 2,300 | 11,500 | 2,300 | ||
Jul 28 2016 | MBVX | MABVAX THERAPEUTIC ... | EISENBERG JEFFREY F | Option Exercise | A | 0.55 | 35,000 | 19,250 | 35,000 | ||
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Executive Vice Pres ... | Option Exercise | D | 11.09 | 71,701 | 795,164 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Executive Vice Pres ... | Option Exercise | D | 14.54 | 52,161 | 758,421 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Executive Vice Pres ... | Option Exercise | D | 22.83 | 23,527 | 537,121 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Executive Vice Pres ... | Option Exercise | D | 13.68 | 30,864 | 422,220 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Executive Vice Pres ... | Option Exercise | D | 22.60 | 50,000 | 1,130,000 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Executive Vice Pres ... | Option Exercise | D | 10.45 | 24,000 | 250,800 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Executive Vice Pres ... | Option Exercise | D | 13.11 | 19,099 | 250,388 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Executive Vice Pres ... | Sell | D | 16.50 | 1,835 | 30,278 | 0 | 1.8 K to 0 (-100.00 %) |
Aug 21 2009 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Executive Vice Pres ... | Sell | U | 16.50 | 11,846 | 195,459 | 1,835 | 13.7 K to 1.8 K (-86.59 %) |
Nov 20 2008 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Executive Vice Pres ... | Option Exercise | A | 11.09 | 71,702 | 795,175 | 71,702 | |
Jan 03 2008 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Executive VP and In ... | Grant | A | 0.00 | 7,342 | 0 | 13,681 | 6.3 K to 13.7 K (+115.82 %) |
Nov 15 2007 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | A | 14.54 | 52,161 | 758,421 | 52,161 | |
Feb 09 2007 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | M | 13.11 | 901 | 11,812 | 19,099 | |
Feb 09 2007 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 27.80 | 901 | 25,048 | 6,339 | 7.2 K to 6.3 K (-12.44 %) |
Feb 09 2007 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Buy | M | 13.11 | 901 | 11,812 | 7,240 | 6.3 K to 7.2 K (+14.21 %) |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | M | 10.45 | 12,000 | 125,400 | 24,000 | |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 25.32 | 2,500 | 63,293 | 6,339 | 8.8 K to 6.3 K (-28.28 %) |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 25.39 | 2,500 | 63,484 | 8,839 | 11.3 K to 8.8 K (-22.05 %) |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 25.40 | 2,500 | 63,500 | 11,339 | 13.8 K to 11.3 K (-18.06 %) |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 25.45 | 2,000 | 50,894 | 13,839 | 15.8 K to 13.8 K (-12.63 %) |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 25.45 | 2,500 | 63,625 | 15,839 | 18.3 K to 15.8 K (-13.63 %) |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Buy | M | 10.45 | 12,000 | 125,400 | 18,539 | 6.5 K to 18.5 K (+183.51 %) |
Nov 16 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | A | 22.83 | 23,527 | 537,121 | 23,527 | |
Oct 27 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | M | 13.11 | 10,000 | 131,100 | 20,000 | |
Oct 27 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 25.80 | 10,000 | 258,000 | 6,339 | 16.3 K to 6.3 K (-61.20 %) |
Oct 27 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Buy | M | 13.11 | 10,000 | 131,100 | 16,339 | 6.3 K to 16.3 K (+157.75 %) |
Oct 12 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | M | 13.11 | 7,420 | 97,276 | 30,000 | |
Oct 12 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.80 | 7,420 | 184,016 | 6,339 | 13.8 K to 6.3 K (-53.93 %) |
Oct 12 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Buy | M | 13.11 | 7,420 | 97,276 | 13,759 | 6.3 K to 13.8 K (+117.05 %) |
Oct 03 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | M | 13.11 | 2,580 | 33,824 | 37,420 | |
Oct 03 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.80 | 2,580 | 63,984 | 6,339 | 8.9 K to 6.3 K (-28.93 %) |
Oct 03 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Buy | M | 13.11 | 2,580 | 33,824 | 8,919 | 6.3 K to 8.9 K (+40.70 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | M | 10.45 | 24,000 | 250,800 | 36,000 | |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | M | 13.11 | 10,000 | 131,100 | 40,000 | |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.42 | 3,000 | 73,260 | 6,339 | 9.3 K to 6.3 K (-32.12 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.40 | 2,000 | 48,792 | 9,339 | 11.3 K to 9.3 K (-17.64 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.39 | 7,000 | 170,730 | 11,339 | 18.3 K to 11.3 K (-38.17 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.36 | 1,000 | 24,360 | 18,339 | 19.3 K to 18.3 K (-5.17 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.31 | 5,000 | 121,550 | 19,339 | 24.3 K to 19.3 K (-20.54 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.28 | 2,000 | 48,560 | 24,339 | 26.3 K to 24.3 K (-7.59 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.24 | 1,000 | 24,240 | 26,339 | 27.3 K to 26.3 K (-3.66 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.21 | 3,000 | 72,630 | 27,339 | 30.3 K to 27.3 K (-9.89 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Buy | M | 10.45 | 24,000 | 250,800 | 30,339 | 6.3 K to 30.3 K (+378.61 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.18 | 2,500 | 60,452 | 6,339 | 8.8 K to 6.3 K (-28.28 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.11 | 2,500 | 60,275 | 8,839 | 11.3 K to 8.8 K (-22.05 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 23.97 | 2,500 | 59,933 | 11,339 | 13.8 K to 11.3 K (-18.06 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 23.84 | 2,500 | 59,600 | 13,839 | 16.3 K to 13.8 K (-15.30 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Buy | M | 13.11 | 10,000 | 131,100 | 16,339 | 6.3 K to 16.3 K (+157.75 %) |
Aug 11 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | M | 8.81 | 5,100 | 44,931 | 0 | |
Aug 11 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Payment of Exercise | F | 20.79 | 2,161 | 44,927 | 6,339 | 8.5 K to 6.3 K (-25.42 %) |
Aug 11 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Buy | M | 8.81 | 5,100 | 44,931 | 8,500 | 3.4 K to 8.5 K (+150.00 %) |
Jul 26 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | M | 10.00 | 18,000 | 180,000 | 0 | |
Jul 26 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 20.00 | 18,000 | 360,000 | 3,400 | 21.4 K to 3.4 K (-84.11 %) |
Jul 26 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Buy | M | 10.00 | 18,000 | 180,000 | 21,400 | 3.4 K to 21.4 K (+529.41 %) |
Mar 17 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | M | 8.81 | 9,500 | 83,695 | 5,100 | |
Mar 17 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 17.36 | 4,000 | 69,450 | 3,400 | 7.4 K to 3.4 K (-54.05 %) |
Mar 17 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 17.31 | 2,000 | 34,620 | 7,400 | 9.4 K to 7.4 K (-21.28 %) |
Mar 17 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 17.28 | 3,500 | 60,480 | 9,400 | 12.9 K to 9.4 K (-27.13 %) |
Mar 17 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Buy | M | 8.81 | 9,500 | 83,695 | 12,900 | 3.4 K to 12.9 K (+279.41 %) |
Nov 17 2005 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | A | 13.68 | 30,864 | 422,220 | 30,864 | |
Nov 12 2004 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | VP & General Counse ... | Option Exercise | A | 22.60 | 50,000 | 1,130,000 | 50,000 | |
Mar 09 2004 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | VP & General Counse ... | Option Exercise | M | 8.81 | 3,400 | 29,954 | 14,600 | |
Mar 09 2004 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | VP & General Counse ... | Option Exercise | M | 4.38 | 14,000 | 61,320 | 0 | |
Mar 09 2004 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | VP & General Counse ... | Payment of Exercise | F | 23.95 | 1,250 | 29,938 | 3,400 | 4.7 K to 3.4 K (-26.88 %) |
Mar 09 2004 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | VP & General Counse ... | Buy | M | 8.81 | 3,400 | 29,954 | 4,650 | 1.3 K to 4.7 K (+272.00 %) |
Mar 09 2004 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | VP & General Counse ... | Sell | S | 23.50 | 5,000 | 117,500 | 1,250 | 6.3 K to 1.3 K (-80.00 %) |
Mar 09 2004 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | VP & General Counse ... | Sell | S | 23.55 | 5,000 | 117,750 | 6,250 | 11.3 K to 6.3 K (-44.44 %) |
Mar 09 2004 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | VP & General Counse ... | Sell | S | 23.58 | 4,000 | 94,320 | 11,250 | 15.3 K to 11.3 K (-26.23 %) |
Mar 09 2004 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | VP & General Counse ... | Buy | M | 4.38 | 14,000 | 61,320 | 15,250 | 1.3 K to 15.3 K (+1,120.00 %) |
Nov 06 2003 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | VP & General Counse ... | Option Exercise | A | 10.45 | 60,000 | 627,000 | 60,000 |
Page: 1